olmesartan has been researched along with boric acid in 2 studies
| Studies (olmesartan) | Trials (olmesartan) | Recent Studies (post-2010) (olmesartan) | Studies (boric acid) | Trials (boric acid) | Recent Studies (post-2010) (boric acid) |
|---|---|---|---|---|---|
| 841 | 185 | 554 | 1,007 | 27 | 397 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Iseki, K; Kikuchi, T; Kusai, A; Sasaki, H; Suzuki, M | 1 |
| Iseki, K; Kikuchi, T; Kusai, A; Nakashima, K; Sasaki, H; Suzuki, M | 1 |
2 other study(ies) available for olmesartan and boric acid
| Article | Year |
|---|---|
Synergistic effect of EDTA and boric acid on corneal penetration of CS-088.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Boric Acids; Cornea; Drug Synergism; Edetic Acid; Imidazoles; Male; Permeability; Rabbits; Tetrazoles | 2005 |
Mechanism of permeability-enhancing effect of EDTA and boric acid on the corneal penetration of 4-[1-hydroxy-1-methylethyl]-2-propyl-1-[4-[2-[tetrazole-5-yl]phenyl]phenyl] methylimidazole-5-carboxylic acid monohydrate (CS-088).
Topics: 1-Octanol; Angiotensin II Type 1 Receptor Blockers; Animals; Boric Acids; Cornea; Drug Synergism; Edetic Acid; Imidazoles; Liposomes; Male; Membrane Fluidity; Ophthalmic Solutions; Particle Size; Permeability; Rabbits; Tetrazoles | 2005 |